Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
1st Source | SRCE | Nov 25, 2024 | 66.19 | -0.15 |
1stdibs.com | DIBS | Nov 25, 2024 | 3.86 | +0.26 |
20+ Year Trsy Bear 3X Direxion | TMV | Nov 25, 2024 | 33.89 | -7.38 |
20+ Year Trsy Bond Ishares | TLT | Nov 25, 2024 | 92.73 | +2.59 |
20+ Year Trsy Bull 3X Direxion | TMF | Nov 25, 2024 | 48.10 | +7.58 |
22nd Century Group | XXII | Nov 25, 2024 | 0.09 | -4.14 |
23andMe | ME | Nov 25, 2024 | 3.29 | +5.79 |
25+ Year Zero Cpn U.S. Trsy Idx ETF Pimco | ZROZ | Nov 25, 2024 | 75.85 | +4.16 |
2seventy bio | TSVT | Nov 25, 2024 | 3.75 | +3.88 |
3-7 Year Treasury Bond Ishares | IEI | Nov 25, 2024 | 116.64 | +0.59 |
30 Year Tips/Tsy Spread Proshares | RINF | Nov 25, 2024 | 32.98 | -1.09 |
36Kr ADR | KRKR | Nov 25, 2024 | 3.08 | -0.65 |
374Water | SCWO | Nov 25, 2024 | 1.03 | +1.98 |
3D Systems | DDD | Nov 25, 2024 | 3.43 | +7.19 |
3M | MMM | Nov 25, 2024 | 130.32 | +1.48 |
4D Molecular Therapeutics | FDMT | Nov 25, 2024 | 7.62 | -2.18 |
51Talk Online Education Group ADR | COE | Nov 25, 2024 | 15.28 | +2.41 |
5E Advanced Materials | FEAM | Nov 25, 2024 | 0.46 | -7.68 |
60 Degrees Pharmaceuticals | SXTP | Nov 25, 2024 | 1.17 | +30.00 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Nov 25, 2024 | 14.01 | -2.91 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Nov 25, 2024 | 25.21 | +3.07 |
7-10 Yr Trsy Ishares | IEF | Nov 25, 2024 | 94.61 | +1.08 |
89bio | ETNB | Nov 25, 2024 | 8.96 | +2.28 |
8x8 | EGHT | Nov 25, 2024 | 3.18 | +4.61 |
908 Devices | MASS | Nov 25, 2024 | 2.70 | +5.47 |
99 Acquisition Group | NNAGU | Nov 25, 2024 | 10.60 | 0.00 |
9F ADR | JFU | Nov 25, 2024 | 1.43 | +4.76 |
A SPAC II Acquisition | ASCB | Nov 25, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Nov 25, 2024 | 30.23 | +1.65 |
a.k.a Brands | AKA | Nov 25, 2024 | 21.13 | -0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.